Molina Healthcare (MOH) Expected to Announce Earnings on Wednesday

Molina Healthcare (NYSE:MOH) is expected to release its Q1 2026 results after the market closes on Wednesday, April 22nd. Analysts expect Molina Healthcare to post earnings of $2.16 per share and revenue of $10.9150 billion for the quarter. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Interested persons can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Thursday, April 23, 2026 at 8:00 AM ET.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Thursday, February 5th. The company reported ($2.75) EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($3.18). The business had revenue of $11.38 billion for the quarter, compared to the consensus estimate of $10.90 billion. Molina Healthcare had a net margin of 1.04% and a return on equity of 13.60%. The business’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same quarter last year, the firm posted $5.05 EPS. On average, analysts expect Molina Healthcare to post $24 EPS for the current fiscal year and $28 EPS for the next fiscal year.

Molina Healthcare Stock Performance

Shares of MOH stock opened at $147.53 on Wednesday. The firm has a market capitalization of $7.68 billion, a PE ratio of 17.23 and a beta of 0.55. The firm has a fifty day simple moving average of $143.41 and a two-hundred day simple moving average of $161.00. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.97. Molina Healthcare has a 12 month low of $121.06 and a 12 month high of $347.79.

Analyst Upgrades and Downgrades

A number of brokerages have commented on MOH. TD Cowen decreased their price target on shares of Molina Healthcare from $175.00 to $144.00 and set a “hold” rating for the company in a research note on Monday, February 9th. Mizuho reduced their target price on shares of Molina Healthcare from $220.00 to $180.00 and set an “outperform” rating for the company in a research note on Thursday, March 12th. The Goldman Sachs Group reduced their target price on shares of Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a research note on Wednesday, February 11th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Molina Healthcare in a research note on Thursday, January 22nd. Finally, Morgan Stanley reduced their target price on shares of Molina Healthcare from $158.00 to $128.00 and set an “equal weight” rating for the company in a research note on Wednesday, March 4th. Two investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Molina Healthcare has an average rating of “Hold” and an average target price of $169.21.

Institutional Trading of Molina Healthcare

Several institutional investors have recently made changes to their positions in MOH. AQR Capital Management LLC grew its stake in shares of Molina Healthcare by 217.0% in the 3rd quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock worth $561,475,000 after acquiring an additional 2,008,458 shares in the last quarter. UBS Group AG grew its stake in shares of Molina Healthcare by 320.7% in the 3rd quarter. UBS Group AG now owns 603,934 shares of the company’s stock worth $115,569,000 after acquiring an additional 460,372 shares in the last quarter. Victory Capital Management Inc. grew its position in Molina Healthcare by 46.4% during the fourth quarter. Victory Capital Management Inc. now owns 1,410,604 shares of the company’s stock valued at $244,796,000 after buying an additional 447,078 shares during the period. Invesco Ltd. grew its position in Molina Healthcare by 24.2% during the fourth quarter. Invesco Ltd. now owns 1,690,981 shares of the company’s stock valued at $293,453,000 after buying an additional 329,679 shares during the period. Finally, Viking Global Investors LP bought a new position in Molina Healthcare during the second quarter valued at about $79,665,000. Institutional investors own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.